Vivos (RDGL) Total Debt Growth (3y) (2014 - 2018)
Vivos (RDGL) Total Debt Growth (3y) (2014 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 26.30% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 4.07% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -0.07% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 6.99% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 0.11% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.61% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -0.34% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -14.39% |
| 10 | Vivos | - | - | -3,105.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 122.82% |
| Jun 30, 2018 | 199.12% |
| Mar 31, 2018 | -83.67% |
| Sep 30, 2017 | -9.17% |
| Jun 30, 2017 | -43.54% |
| Mar 31, 2017 | -7.53% |
| Dec 31, 2016 | 8.91% |
| Sep 30, 2016 | -37.94% |
| Jun 30, 2016 | 6.18% |
| Dec 31, 2015 | 395.15% |
| Sep 30, 2015 | 323.21% |
| Jun 30, 2015 | 19.29% |
| Mar 31, 2015 | 272.12% |
| Jun 30, 2014 | 238.44% |